News & Perspective

Nov 04, 2011

Nov 04, 2011

Flu vaccine efficacy: Time to revise public messages?

(CIDRAP News) – For many years, public health personnel have cited the estimate of 70% to 90% when talking about the level of protection afforded by seasonal influenza vaccines. But last week's meta-analysis of flu vaccine studies in The Lancet Infectious Diseases—along with several other studies in recent years—has raised the question of whether it's time to change the message about flu vaccines.

Oct 25, 2011

Oct 25, 2011

Public health groups say flu vaccine is best tool, despite limitations

Editor’s Note: This article covers research conducted in part by CIDRAP researchers. Please note that CIDRAP News operates independently in relation to CIDRAP's research and policy programs.

See also: Strict meta-analysis raises questions about flu vaccine efficacy